These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34275119)
21. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer. Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009 [TBL] [Abstract][Full Text] [Related]
22. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes. Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060 [TBL] [Abstract][Full Text] [Related]
23. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010 [TBL] [Abstract][Full Text] [Related]
24. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer. Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787 [TBL] [Abstract][Full Text] [Related]
25. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2. Sakamoto E; Hato F; Kato T; Sakamoto C; Akahori M; Hino M; Kitagawa S J Leukoc Biol; 2005 Jul; 78(1):301-9. PubMed ID: 15845643 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of the SOCS1-JAK2-STAT3 Signaling Pathway Confers Neuroprotection in Rats with Ischemic Stroke. Wang XL; Qiao CM; Liu JO; Li CY Cell Physiol Biochem; 2017; 44(1):85-98. PubMed ID: 29130998 [TBL] [Abstract][Full Text] [Related]
27. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts. Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216 [TBL] [Abstract][Full Text] [Related]
28. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway. Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793 [TBL] [Abstract][Full Text] [Related]
29. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. Song MM; Shuai K J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039 [TBL] [Abstract][Full Text] [Related]
30. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice. Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131 [TBL] [Abstract][Full Text] [Related]
31. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764 [TBL] [Abstract][Full Text] [Related]
32. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030 [TBL] [Abstract][Full Text] [Related]
33. Interferon-γ stimulates human follicular dendritic cell-like cells to produce prostaglandins via the JAK-STAT pathway. Kim J; Yoon Y; Jeoung D; Kim YM; Choe J Mol Immunol; 2015 Aug; 66(2):189-96. PubMed ID: 25818476 [TBL] [Abstract][Full Text] [Related]
34. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517 [TBL] [Abstract][Full Text] [Related]
35. Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. Jeon SB; Yoon HJ; Chang CY; Koh HS; Jeon SH; Park EJ J Immunol; 2010 Dec; 185(11):7037-46. PubMed ID: 20980634 [TBL] [Abstract][Full Text] [Related]
36. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways. Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479 [TBL] [Abstract][Full Text] [Related]
37. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. Gingras S; Parganas E; de Pauw A; Ihle JN; Murray PJ J Biol Chem; 2004 Dec; 279(52):54702-7. PubMed ID: 15491990 [TBL] [Abstract][Full Text] [Related]
38. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients. Liu B; Chen S; Guan Y; Chen L PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702 [TBL] [Abstract][Full Text] [Related]
39. Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling. DiGiandomenico A; Wylezinski LS; Hawiger J Sci Signal; 2009 Jul; 2(80):ra37. PubMed ID: 19622834 [TBL] [Abstract][Full Text] [Related]
40. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]